| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/10/2012 | CA2246760C Polysaccharide-peptide-conjugates |
| 01/10/2012 | CA2222328C Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 01/10/2012 | CA2124259C Galenical formulations |
| 01/05/2012 | WO2012003476A2 Hapten conjugates for target detection |
| 01/05/2012 | WO2012003470A2 Antibody formulations |
| 01/05/2012 | WO2012003466A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | WO2012003398A1 Method for uses of protein precursors as prodrugs |
| 01/05/2012 | WO2012003370A2 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 01/05/2012 | WO2012003365A1 Filaments comprising an ingestible active agent nonwoven webs and methods for making same |
| 01/05/2012 | WO2012003361A2 Nanoemulsion vaccines |
| 01/05/2012 | WO2012003350A1 Methods of delivering a health care active by administering personal health care articles comprising a filament |
| 01/05/2012 | WO2012003290A2 Dental composites comprising nanoparticles of amorphous calcium phosphate |
| 01/05/2012 | WO2012003181A2 Solid forms |
| 01/05/2012 | WO2012002760A2 Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 01/05/2012 | WO2012002759A2 Microvesicles derived from cell protoplast, and use thereof |
| 01/05/2012 | WO2012002745A2 Factor viia complex using an immunoglobulin fragment |
| 01/05/2012 | WO2012002715A2 Temperature-sensitive bioactive material carrier and method for preparing same |
| 01/05/2012 | WO2012002644A2 Sustained-release pharmaceutical composition containing pramipexole or pharmaceutically acceptable salt thereof with improved stability |
| 01/05/2012 | WO2012002640A2 Transdermal drug delivery system containing donepezil |
| 01/05/2012 | WO2012002547A1 Bosentan solid dispersion |
| 01/05/2012 | WO2012002464A1 ω3 FATTY ACID COMPOUND PREPARATION |
| 01/05/2012 | WO2012002391A1 Nanofibre laminate sheet |
| 01/05/2012 | WO2012002388A1 Drug delivery agent to sentinel lymph node |
| 01/05/2012 | WO2012002253A1 Composite particles which contain both cellulose and inorganic compound |
| 01/05/2012 | WO2012001977A1 Disintegrating composition and easily disintegrating compression molded article |
| 01/05/2012 | WO2012001641A1 Stable pharmaceutical compositions |
| 01/05/2012 | WO2012001403A1 Topical pharmaceutical composition comprising flurbiprofen |
| 01/05/2012 | WO2012001298A1 Cosmetic composition comprising peba |
| 01/05/2012 | WO2012001009A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution |
| 01/05/2012 | WO2012000610A1 Complexes with polystyrene sulfonate |
| 01/05/2012 | WO2012000187A1 Fusion protein of g-csf variant, preparation method and use thereof |
| 01/05/2012 | WO2012000118A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/05/2012 | WO2012000104A1 Non-liposomal systems for nucleic acid delivery |
| 01/05/2012 | WO2011142858A3 Chlorotoxin variants, conjugates, and methods for their use |
| 01/05/2012 | WO2011135141A4 Modified oligonucleotides as regulators of gene expression |
| 01/05/2012 | WO2011116371A3 Polyplex gene delivery vectors |
| 01/05/2012 | WO2011112558A3 Solid compositions |
| 01/05/2012 | WO2011109834A3 Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1 |
| 01/05/2012 | WO2011109365A3 Concentrated protein formulations and uses thereof |
| 01/05/2012 | WO2011091098A3 Tooth whitening accelerator formulation and method of using the same |
| 01/05/2012 | WO2011088229A3 Active self-healing biomaterial system |
| 01/05/2012 | WO2011080271A3 Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof |
| 01/05/2012 | WO2011074006A4 Vaccine composition |
| 01/05/2012 | WO2011064316A3 Mucosal delivery compositions comprising a peptide complexed with a crown comppound and/or a counter ion |
| 01/05/2012 | WO2011055139A3 Antimicrobial and anti-acne formulations |
| 01/05/2012 | US20120004422 Intermediates Useful in the Preparation of Maleimide Functionalized Polymers |
| 01/05/2012 | US20120004396 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 01/05/2012 | US20120004327 Water-insoluble reaction product of a polyamine and an oil-soluble high carbon polar modified polymer |
| 01/05/2012 | US20120004324 Process for Preparing Cyclic Esters Comprising Unsaturated Functional Groups and Polyesters Prepared From Same |
| 01/05/2012 | US20120004323 Implant processing methods for thermally labile and other bioactive agents and implants prepared from same |
| 01/05/2012 | US20120004321 Orally Disintegrating Tablet |
| 01/05/2012 | US20120004305 External preparation containing analgesic/anti-inflammatory agent |
| 01/05/2012 | US20120004293 Cancer Cell Targeting Using Nanoparticles |
| 01/05/2012 | US20120004255 Dual phase drug release system |
| 01/05/2012 | US20120004189 Compositions and products containing s-equol, and methods for their making |
| 01/05/2012 | US20120004177 Compositions and methods of delivery of pharmacological agents |
| 01/05/2012 | US20120004176 Liquid Composition of Factor VII Polypeptides |
| 01/05/2012 | US20120004170 Formulation Comprising Bioactive Agents And Method Of Using Same |
| 01/05/2012 | US20120004158 Quaternised Ammonium Cyclodextrin Compounds |
| 01/05/2012 | US20120003629 Biological control of nanoparticle nucleation, shape and crystal phase |
| 01/05/2012 | US20120003322 Ph-sensitive dendritic polymeric micelles |
| 01/05/2012 | US20120003311 Method for controlled release of an acid-unstable physiologically active substance |
| 01/05/2012 | US20120003248 Monomethylvaline compounds capable of conjugation to ligands |
| 01/05/2012 | US20120003247 Monomethylvaline compounds capable of conjugation to ligands |
| 01/05/2012 | US20120003206 Liquid, aqueous pharmaceutical compositions of factor vii polypeptides |
| 01/05/2012 | US20120003198 Lutein/Zeaxanthin for glare protection |
| 01/05/2012 | US20120003192 Hydrogel-forming composition comprising protein and non-protein segments |
| 01/05/2012 | US20120003176 Hydrogel-forming composition comprising natural and synthetic segments |
| 01/05/2012 | US20120003155 Dendrimer based nanodevices for therapeutic and imaging purposes |
| 01/05/2012 | CA2804760A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | CA2804201A1 Stable antiseptic compositions and methods |
| 01/05/2012 | CA2804149A1 Nanoemulsion vaccines |
| 01/05/2012 | CA2804148A1 Transdermal drug delivery system containing donepezil |
| 01/05/2012 | CA2803998A1 Antibody formulations |
| 01/05/2012 | CA2803983A1 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 01/05/2012 | CA2803646A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/05/2012 | CA2803558A1 .omega.3 fatty acid compound preparation |
| 01/05/2012 | CA2803377A1 Methods of delivering a health care active by administering personal health care articles comprising a filament |
| 01/05/2012 | CA2802816A1 Polymeric system for delivering a preservative-free prostaglandin-based nonviscous solution |
| 01/05/2012 | CA2802303A1 Pharmaceutical compositions comprising paracetamol and process for preparing the same |
| 01/05/2012 | CA2800936A1 Hapten conjugates for target detection |
| 01/05/2012 | CA2798028A1 Liquid formulations of rupatadine fumarate |
| 01/04/2012 | EP2402429A1 Equol-producing bacterium and use thereof |
| 01/04/2012 | EP2402350A1 New water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins. |
| 01/04/2012 | EP2402037A1 Controlled release of phenolic opioids |
| 01/04/2012 | EP2402036A1 Cyclodextrin-based polymers for delivering the therapeutic agents covalently attached thereto |
| 01/04/2012 | EP2402035A1 Coating material for solid medicine and solid medicine formed with same |
| 01/04/2012 | EP2402032A1 Immunogenic composition |
| 01/04/2012 | EP2402017A1 Carbon monoxide removal agent |
| 01/04/2012 | EP2402010A1 Solid drug for oral use |
| 01/04/2012 | EP2402008A1 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| 01/04/2012 | EP2402007A1 Coenzyme q10-containing composition for oral ingestion |
| 01/04/2012 | EP2402006A1 Bandseal for peg-filled hard capsule |
| 01/04/2012 | EP2402001A1 Formulations for alteration of biophysical properties of mucosal lining |
| 01/04/2012 | EP2401251A2 Guanidino-substituted bi- and polyphenyls as small molecule carriers |
| 01/04/2012 | EP2401225A2 A supramolecular approach for preparation of size controllable nanoparticles |
| 01/04/2012 | EP2401024A2 Devices, systems and methods for magnetic-assisted therapeutic agent delivery |
| 01/04/2012 | EP2400989A1 Oligomer-amino acid conjugates |
| 01/04/2012 | EP2400988A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 01/04/2012 | EP2400987A1 Bendamustine cyclopolysaccharide compositions |